Establishment Labs Announces Participation in The Aesthetic Meeting 2022 and Sessions of Interest

3 years ago

SANTA BARBARA, Calif.--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the…

TRUVIC Announces 510(k) Clearance for the Prodigy™ Thrombectomy System

3 years ago

First regulatory milestone as part of a strategy to advance patient care CAMPBELL, Calif.--(BUSINESS WIRE)--Truvic Medical, Inc., a wholly owned…

Equideum Health and Nokia Bell Labs Collaborate to Empower Individuals to Own and Benefit from Health Data Sourced from Edge Devices

3 years ago

Equideum Health and Nokia Bell Labs are collaborating with a focus on integrating and leveraging edge datasets to be made…

Chairman W. Stancil Starnes to Retire From ProAssurance Board of Directors

3 years ago

BIRMINGHAM, Ala.--(BUSINESS WIRE)--ProAssurance Corporation (NYSE:PRA) today announced that W. Stancil (Stan) Starnes, Executive Chairman of the Board of Directors, will…

Biomarker-Guided Trial Led by University Hospital Hamburg-Eppendorf (UKE) Opens New Avenues for Personalized Medicine in COVID-19

3 years ago

A multi-center study led by UKE is evaluating one of the first personalized approaches for moderate to severe COVID-19 patients.The…

Notice to Annual General Meeting of Spago Nanomedical AB (publ)

3 years ago

LUND, SWEDEN / ACCESSWIRE / April 11, 2022 / Spago Nanomedical (STO:SPAGO.ST)(FRA:7UX.F)The shareholders of Spago Nanomedical AB (publ), corporate registration…

AnPac Bio Appoints Dr. Aidong Chen as New Chief Executive Officer and Chairman of the Board and Miss Sheng Liu as a New Board Member

3 years ago

PHILADELPHIA, April 08, 2022 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (ANPC), a…

Junshi Biosciences and Coherus Present Results of Phase 3 Study of Toripalimab in First Line Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma at 2022 AACR Annual Meeting

3 years ago

- Toripalimab plus chemotherapy provided superior progression free survival, overall survival, overall response rate and duration of response compared to…

Forward Pharma Reports Financial and Operating Results for the Year Ended December 31, 2021

3 years ago

COPENHAGEN, Denmark, April 08, 2022 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“we,” “Forward” or the “Company” and, together with…

Shattuck Labs Presents Preclinical Data at the 2022 American Association for Cancer Research (AACR) Annual Meeting

3 years ago

- SL-9258 (TIGIT-Fc-LIGHT) combined with anti-PD(L)1 broadened anti-tumor activity of the checkpoint antibodies in aggressive CPI-resistant tumors - - Butyrophilin…